Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC254028 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RNASE11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNASE4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM55B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APEX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDDM3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSGEP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDDM3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNASE6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNASE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on